A common question when using ML models for virtual screening is whether the newly identified hits are truly novel or merely analogous to the existing hits used for ML model training. While enriched DEL compounds (PTEs, binders) are not strictly "existing hits," a similar question arises: is the model discovering hits outside the chemical space covered by the DEL, or is it simply "translating" DEL hits into analogs found in the screening set?